InvestorsHub Logo

mick

04/04/20 8:22 PM

#508699 RE: mick #508698

SARS-CoV-2 RNA Controls Twist Bioscience Corp. Said its synthetic SARS-CoV-2 RNA Controls have been added to the FDA website as reference materials for development, verification and validation of SARS-CoV-2 tests

https://www.bioworld.com/COVID19diagnostics

NGS panels Twist Bioscience Corp. Made available research-use only target enrichment next-generation sequencing panels for viral detection and characterization of samples from patients testing positive for SARS-CoV-2, which causes COVID-19; also launched next-generation sequencing target enrichment panel for SARS-CoV-2/COVID-19 research that can be used for environmental monitoring and surveillance testing, as well as insights into full sequence information to track viral evolution and strain origin